Skip to content

NAM prevention survey results: testing underestimated, support for treatment as prevention, reservations about PrEP

The biggest change is still in the future, by Paul Clift

The biggest change is still in the future, by Paul Clift

Surviving, thriving and supporting others, by Winnie Ssanyu-Sseruma

Surviving, thriving and supporting others, by Winnie Ssanyu-Sseruma

Thirty years as an NHS consultant, by Professor Brian Gazzard

Thirty years as an NHS consultant, by Professor Brian Gazzard

Whatever the future holds, it’s in all our hands, by Lisa Power

Whatever the future holds, it’s in all our hands, by Lisa Power

How it’s changed, by Edwin J Bernard

How it’s changed, by Edwin J Bernard

Severity of HIV seroconversion illness associated with subsequent disease progression

For women, HIV treatment based on atazanavir/ritonavir involves twice the risk of failure compared to efavirenz-containing therapy

Hepatitis C virus dried on inanimate surfaces can remain infectious for up to six weeks